Telomere-driven diseases and telomere-targeting therapies
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
Telomeres, the protective ends of linear chromosomes, shorten throughout an individual’s lifetime. Telomere shortening is proposed to be a primary molecular cause of aging. Short telomeres block the proliferative capacity of stem cells, affecting their potential to regenerate tissues, and trigger the development of age-associated diseases. Mutations in telomere maintenance genes are associated with pathologies referred to as telomere syndromes, including Hoyeraal-Hreidarsson syndrome, dyskeratosis congenita, pulmonary fibrosis, aplastic anemia, and liver fibrosis. Telomere shortening induces chromosomal instability that, in the absence of functional tumor suppressor genes, can contribute to tumorigenesis. In addition, mutations in telomere length maintenance genes and in shelterin components, the protein complex that protects telomeres, have been found to be associated with different types of cancer. These observations have encouraged the development of therapeutic strategies to treat and prevent telomere-associated diseases, namely aging-related diseases, including cancer. Here we review the molecular mechanisms underlying telomere-driven diseases and highlight recent advances in the preclinical development of telomere-targeted therapies using mouse models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therapeutic benefits have been observed for AAV-mediated delivery of TERT in animal models of aplastic anaemia, IPF and Alzheimer’s disease164,191.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [191]
Experimental — accuracy not yet measuredIn the citing paper
“Genetic defects in telomere maintenance cause human telomeropathies, including dyskeratosis congenita, aplastic anemia, and pulmonary and liver disease exhibiting multiple progeroid features15.”
From The central role of DNA damage in the ageing process (2021) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 3×
“Telomeres shorten progressively throughout an individual’s lifetime (Cawthon et al., 2003; López-Otín et al., 2013; Sanders and Newman, 2013).”
BackgroundSelf-citationSpecific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 3×
“Indeed, ∼90% of human cancers present telomerase activity (Kim et al., 1994).”
BackgroundAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 1×
“MC is driven by a complex and poorly understood signaling cascade that antecedes apoptosis, necrosis, senescence, or autophagy (Levine and Kroemer, 2008; Vitale et al., 2011).”
BackgroundTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 2×
“…to counteract telomere attrition associated with cell division throughout life, and therefore telomeres shorten with age in vitro and in vivo (Harley et al., 1990; Hastie et al., 1990; Lindsey et al., 1991; Collado et al., 2007; Liu et al., 2007; Flores et al., 2008; Marion et al., 2009).”
BackgroundAutophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 2×
“1 C; Greider and Blackburn, 1985).”
BackgroundShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“1 C; de Lange, 2005; Martínez and Blasco, 2010, 2011).”
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 2×
“1, A and B; Griffith et al., 1999; Doksani et al., 2013).”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108 · cited 1×
“…the study of telomerase-deficient mice, which show premature aging phenotypes in both lowproliferating (heart, brain) and high-proliferating compartments (bone marrow [BM], gut, skin, and testis; Blasco et al., 1997; Lee et al., 1998; Herrera et al., 1999; Leri et al., 2003; Ferrón et al., 2004).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Bär, 2016, F1000 Res, 89
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Molecular mechanisms of aging and anti-aging strategies
Li, Y., Tian, X., Luo, J., Bao, T., Wang, S., & Wu, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01663-1 · Cited by 293
“Excellent telomere and telomerase structures are essential for ensuring the normal physiological function of mothers and offspring, and their integrity has a certain genetic intergenerational effect [102, 103].”
BackgroundOxidative Stress in Pulmonary Fibrosis
Otoupalova, E., Smith, S., Cheng, G., & Thannickal, V. J. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190017 · Cited by 262
“Telomere shortening is associated with aging and age-related diseases, including IPF (20, 355, 376).”
Targeting immune dysfunction in aging
Borgoni, S., Kudryashova, K. S., Burka, K., & de Magalhães, J. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101410 · Cited by 223
“Several therapeutic strategies for telomere elongation or telomerase induction are currently under investigation (Martínez and Blasco, 2017).”
BackgroundPlatzbecker, U., Santini, V., Fenaux, P., Sekeres, M. A., Savona, M. R., Madanat, Y. F., Díez‐Campelo, M., Valcárcel, D., Illmer, T., Jonasova, A. T., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01724-5 · Cited by 151
Telomerase-Targeted Cancer Immunotherapy
Mizukoshi, E., & Kaneko, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081823 · Cited by 120
Mouse Models to Disentangle the Hallmarks of Human Aging
Folgueras, A. R., Freitas-Rodríguez, S., Velasco, G., & López-Otín, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.312204 · Cited by 113
“are characterized by the impairment of the self-renewal capacity of different tissues.(65)”
BackgroundTelomeres, Telomerase and Ageing
Saretzki, G. (2018) · Subcellular Biochemistry · doi:10.1007/978-981-13-2835-0_9 · Cited by 93
Shorter telomere lengths in patients with severe COVID-19 disease
Sánchez-Vazquez, R., Guío-Carrión, A., Zapatero, A., Martínez, P., & Blasco, M. A. (2021) · Aging · doi:10.18632/aging.202463 · Cited by 114
“As short telomeres can be elongated by telomerase, and telomerase activation strategies have been shown by us to delay aging and age related pathologies [50], as well as to have therapeutic effects in diseases associated to short telomeres, such as pulmonary fibrosis [44], it is tempting to speculate that such telomer…”
BackgroundSelf-citationMolecular mechanisms of telomere biology disorders
Grill, S., & Nandakumar, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.014017 · Cited by 119
“For a more thorough discussion of the existing models and therapeutics, we point the reader to this review (23).”
BackgroundGarus, A., & Autexier, C. (2021) · RNA · doi:10.1261/rna.078953.121 · Cited by 109
Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside
Mangaonkar, A. A., & Patnaik, M. M. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.03.020 · Cited by 100
“Telomeres are flanked by special regions, called the shelterin complex, that regulate telomere lengths and protect them from DNA damage response.(1) The shelterin complex comprises”
EMT and Stemness—Key Players in Pancreatic Cancer Stem Cells
Rodríguez-Aznar, E., Wiesmüller, L., Sáinz, B., & Hermann, P. C. (2019) · Cancers · doi:10.3390/cancers11081136 · Cited by 108
“CSCs are also endowed with telomere length stabilization mechanisms in order to keep unlimited self-renewal leading to cellular immortalization [79].”
BackgroundMa, X.-R., Zhu, X., Xiao, Y., Gu, H.-M., Zheng, S., Li, L., Wang, F., Dong, Z.-J., Wang, D.-X., Wu, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28844-1 · Cited by 101
Telomere length: lights and shadows on their role in human reproduction
Rocca, M. S., Foresta, C., & Ferlin, A. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy208 · Cited by 104
“On these bases, telomeres have assumed great importance especially in the fields of oncology and age-related diseases and research is focusing on telomeres as a potential target for therapeutic strategies [1, 2].”
BackgroundIs DNA damage indispensable for stress-induced senescence?
Bielak-Żmijewska, A., Mosieniak, G., & Sikora, E. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.004 · Cited by 92
Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions
Porter, S. R., Gueiros, L. A., Leão, J. C., & Fedele, S. (2018) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.03.008 · Cited by 88
The mTOR pathway is necessary for survival of mice with short telomeres
Ferrara‐Romeo, I., Martínez, P., Saraswati, S., Whittemore, K., Graña‐Castro, O., Poluha, L. T., Serrano, R., Hernández-Encinas, E., Blanco‐Aparicio, C., Flores, J. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14962-1 · Cited by 77
Self-citationMartínez, P., & Blasco, M. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312202 · Cited by 82
Self-citationBanyasz, A., Martínez-Fernández, L., Balty, C., Perron, M., Douki, T., Improta, R., & Markovitsi, D. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05931 · Cited by 72
Wang, L., Tu, Z., Liu, C., Liu, H., Kaldis, P., Chen, Z., & Li, W. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0037-8 · Cited by 70
The Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging
Farr, J. N., & Almeida, M. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3564 · Cited by 73
“Taken together, these discoveries have stimulated the development of preclinical telomere-targeted therapeutic approaches to delay aging.((32))”
BackgroundBahrami, A., Bo, S., Jamialahmadi, T., & Sahebkar, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101024 · Cited by 71
Pulmonary phenotypes associated with genetic variation in telomere-related genes
Hoffman, T. W., van Moorsel, C. H. M., Borie, R., & Crestani, B. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000475 · Cited by 70
Yu, J., Yuan, X., Sjöholm, L. K., Liu, T., Kong, F., Ekström, T. J., Björkholm, M., & Xu, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.013 · Cited by 64
DNA folds threaten genetic stability and can be leveraged for chemotherapy
Zell, J., Sperti, F. R., Britton, S., & Monchaud, D. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00151a · Cited by 62
Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
Gatzka, M. (2018) · Cancers · doi:10.3390/cancers10060155 · Cited by 61
“the catalytic subunit of telomerase), shelterin complex proteins (TRF1, TRF2, POT1, TIN2, TPP1, and Rap1), and telomerase-associated proteins (such as hTEP, p23, HSP90 and dyskerin)—are relatively frequently activated or mutated in tumors including both familial and acquired melanoma, often in context with BRAF mutati…”
BackgroundAging, Cancer, and Inflammation: The Telomerase Connection
Boccardi, V., & Marano, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158542 · Cited by 73
“New evidence suggests that aging is driven by chronic inflammation, which depletes stem cells, disrupts cellular communication, and leads to telomere loss-telomeres being protective “caps” at chromosome ends [8].”
BackgroundLaprade, H., Querido, E., Smith, M. J., Guérit, D., Crimmins, H., Conomos, D., Pourret, E., Chartrand, P., & Sfeir, A. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.005 · Cited by 64
Replication Stress at Telomeric and Mitochondrial DNA: Common Origins and Consequences on Ageing
Billard, P., & Poncet, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194959 · Cited by 65
“This process is a well-known motor for cancer development, a disease associated with ageing, and has been especially well documented in the context of telomere replication-helper deficiency (for review, see [7]).”
BackgroundRusso, P., Prinzi, G., Proietti, S., Lamonaca, P., Frustaci, A., Boccia, S., Amore, R., Lorenzi, M., Onder, G., Marzetti, E., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.07.015 · Cited by 60
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 58
“If this damage is irreparable, signaling drives cells into replicative senescence [73].”
BackgroundFenech, M. F., Bull, C. F., & van Klinken, B. J. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.004 · Cited by 63
“Telomere length can be measured at the single chromosome or nucleus level using molecular probes that hybridize to the TTAGGG sequence or by polymerase chain reaction (PCR) [12 – 14].”
MethodGuerra, L., Castori, M., Didona, B., Castiglia, D., & Zambruno, G. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14834 · Cited by 59
The Phosphorylated Form of the Histone H2AX (γH2AX) in the Brain from Embryonic Life to Old Age
Merighi, A., Gionchiglia, N., Granato, A., & Lossi, L. (2021) · Molecules · doi:10.3390/molecules26237198 · Cited by 58
“Telomeres, the protecting ends of linear chromosomes, become shorter at every cell division, and their shortening is proposed to be a primary cause of aging, cellular senescence, and numerous diseases [36].”
BackgroundSahu, S., Dattani, A., & Aboobaker, A. A. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.028 · Cited by 57
Platella, C., Guida, S., Bonmassar, L., Aquino, A., Bonmassar, E., Ravagnan, G., Montesarchio, D., Roviello, G. N., Musumeci, D., & Fuggetta, M. P. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.08.001 · Cited by 48
Denham, J., & Sellami, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101411 · Cited by 56
Telomeres: New players in immune-mediated inflammatory diseases?
Heba, A.-C., Toupance, S., Arnone, D., Peyrin‐Biroulet, L., Bénétos, A., & Ndiaye, N. C. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102699 · Cited by 55
“Anti-aging or regenerative applications require telomeres up-regulation, which is often associated with telomere attrition [225].”
BackgroundThe Importance of Telomere Shortening for Atherosclerosis and Mortality
Herrmann, W., & Herrmann, M. (2020) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd7030029 · Cited by 49
Telomere Shortening and Its Association with Cell Dysfunction in Lung Diseases
Ruíz, A., Flores‐González, J., Buendía-Roldán, I., & Chávez‐Galán, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010425 · Cited by 49
Telomerase: A prominent oncological target for development of chemotherapeutic agents
Vishwakarma, K., Dey, R., & Bhatt, H. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115121 · Cited by 46
Genome-Protecting Compounds as Potential Geroprotectors
Proshkina, E., Shaposhnikov, M. V., & Moskalev, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124484 · Cited by 45
“The loss of function of telomerase causes diseases characterized by premature aging, in particular, dyskeratosis congenita and its severe form, Hoyeraal–Hreidarsson syndrome [7,74,81].”
BackgroundInfluentialΤelomerase inhibitors and activators in aging and cancer: A systematic review
Fragkiadaki, P., Renieri, E. A., Kalliantasi, K., Kouvidi, E., Apalaki, E., Vakonaki, E., Mamoulakis, C., Spandidos, D. A., & Tsatsakis, A. M. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12674 · Cited by 44
“From a clinical aspect, there are indications that telomerase is an effective target that results in the improvement of a number of human cancer types, while exerting minimal side‐effects (58,59).”
BackgroundDerevyanko, A., Whittemore, K., Schneider, R. P., Jiménez, V., Bosch, F., & Blasco, M. A. (2017) · Aging Cell · doi:10.1111/acel.12677 · Cited by 44
“Importantly, we have previously demonstrated that stem cell compartments exhibit increased TRF1 expression and that TRF1 is necessary for tissue homeostasis even in the presence of a normal telomere length (Mart ınez et al., 2009; Schneider et al., 2013).”
BackgroundInfluentialSelf-citationMuñoz-Lorente, M. A., Martínez, P., Tejera, Á., Whittemore, K., Moisés-Silva, A. C., Bosch, F., & Blasco, M. A. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007562 · Cited by 40
“However, there is mounting evidence that short telomeres can also lead to increased cancer, especially owing to accumulation of chromosome aberrations if DNA damage checkpoints are lost, such as p53 loss [61, 67, 68].”
BackgroundSelf-citationOvarian rescue in women with premature ovarian insufficiency: facts and fiction
Pellicer, N., Cozzolino, M., Díaz‐García, C., Galliano, D., Cobo, A. C., Pellicer, A., & Herraiz, S. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.12.011 · Cited by 42
Histone Modifications and the Maintenance of Telomere Integrity
Jezek, M., & Green, E. M. (2019) · Cells · doi:10.3390/cells8020199 · Cited by 44
“Telomere syndromes, or telomeropathies, are genetic disorders that have generally been linked to germline mutations in genes encoding telomere maintenance factors, including telomerase subunits and the proteins required for its function, such as DKC1, as well as telomere protection factors, including shelterin compone…”
BackgroundRecurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita
Kirschner, M., Maurer, A., Włodarski, M. W., Ferreira, M. S. V., Bouillon, A., Halfmeyer, I., Blau, W., Kreuter, M., Rosewich, M., Corbacioglu, S., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0125-x · Cited by 39
Furtado, C. L. M., Luchiari, H. R., Pedroso, D. C. C., Kogure, G. S., Caetano, L. C., Santana, B. A., Santana, V. P., Benetti‐Pinto, C. L., dos Reis, F. M., Maciel, M. A., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.017 · Cited by 39
He, H., Li, W., Comiskey, D. F., Liyanarachchi, S., Nieminen, T. T., Wang, Y., DeLap, K. E., Brock, P. L., & de la Chapelle, A. (2020) · Thyroid · doi:10.1089/thy.2019.0156 · Cited by 42
Comprehensive Study of Guanine Excited State Relaxation and Photoreactivity in G-quadruplexes
Martínez‐Fernández, L., Changenet‐Barret, P., Bányász, Á., Gustavsson, T., Markovitsi, D., & Improta, R. (2019) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.9b02740 · Cited by 37
TRF2 Mediates Replication Initiation within Human Telomeres to Prevent Telomere Dysfunction
Drosopoulos, W. C., Deng, Z., Twayana, S., Kosiyatrakul, S. T., Vladimirova, O. V., Lieberman, P. M., & Schildkraut, C. L. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108379 · Cited by 39
“Genomic instability resulting from telomere dysfunction is an important contributing factor to cancer as well as congenital and age-related degenerative diseases (Blackburn et al., 2015; Martínez and Blasco, 2017).”
Martínez‐Fernández, L., Esposito, L., & Improta, R. (2020) · Photochemical & Photobiological Sciences · doi:10.1039/d0pp00065e · Cited by 34
Telomere length correlates with subtelomeric DNA methylation in long-term mindfulness practitioners
Mendióroz, M., Puebla‐Guedea, M., Montero‐Marín, J., Urdánoz‐Casado, A., Blanco‐Luquin, I., Roldán, M., Labarga, A., & García‐Campayo, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-61241-6 · Cited by 39
Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues
Alle, Q., Le Borgne, E., Milhavet, O., & Lemaitre, J.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083990 · Cited by 35
Caloric Restriction Research: New Perspectives on the Biology of Aging
Anderson, R. M., Couteur, D. G. L., & de Cabo, R. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx212 · Cited by 35
“One of the earliest models to explain biology of aging, and the subject of Nobel prize-wining research, centers on telomeres (28).”
BackgroundAli, J. H., & Walter, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03041-2 · Cited by 39
“…[88, 89, 132], alternative splicing with splice-switching oligonucleotides [133, 134–137, 206, 208], the use of phytochemicals with a wide variety of different targets [257]; Crisp/ Cas9 based and other telomere deprotection measures [183, 184, 187]; the use of ATR inhibitors [217, 218–221].”
BackgroundProtsenko, E., Rehkopf, D. H., Prather, A. A., Epel, E. S., & Lin, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240185 · Cited by 35
Tieing together loose ends: telomere instability in cancer and aging
Borges, G. D. O., Criqui, M., & Harrington, L. A. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13299 · Cited by 37
Short and dysfunctional telomeres sensitize the kidneys to develop fibrosis
Saraswati, S., Martínez, P., Graña-Castro, O., & Blasco, M. A. (2021) · Nature Aging · doi:10.1038/s43587-021-00040-8 · Cited by 28
Self-citationExploring mechanisms of skin aging: insights for clinical treatment
Zhang, M., Lin, Y., Han, Z., Huang, X., Zhou, S., Wang, S., Zhou, Y., Han, X., & Chen, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1421858 · Cited by 49
Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
Brane, A. C., & Tollefsbol, T. O. (2019) · Cells · doi:10.3390/cells8020186 · Cited by 36
“This result also exemplifies Notch1’s role in cancer, due to evidence that telomeric shortening is important for early tumorigenesis [12,49].”
BackgroundPathology, Radiology, and Genetics of Interstitial Lung Disease in Patients With Shortened Telomeres
Cecchini, M. J., Tarmey, T., Ferreira, A. J., Mangaonkar, A. A., Ferrer, A., Patnaik, M. M., Wylam, M. E., Jenkins, S. M., Spears, G. M., Yi, E. S., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001725 · Cited by 30
New insights into vascular aging: Emerging role of mitochondria function
Li, Y., Jin, X., Li, D. X., Lu, J. Z., Zhang, X., Yang, S., Zhao, Y., & Wu, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113954 · Cited by 32
Denham, J. (2023) · Aging Cell · doi:10.1111/acel.13836 · Cited by 28
“Extensive discussion on telomere- based therapies can be found here (Chakravarti et al., 2021; Martinez & Blasco, 2017; Yeh et al., 2019).”
BackgroundImpact of Ovarian Aging in Reproduction: From Telomeres and Mice Models to Ovarian Rejuvenation.
Polonio, A. M., Chico-Sordo, L., Córdova-Oriz, I., Medrano, M., García-Velasco, J. A., & Varela, E. (2020) · The Yale Journal of Biology and Medicine · Cited by 46
Reproductive aging and telomeres: Are women and men equally affected?
Chico-Sordo, L., Córdova-Oriz, I., Polonio, A. M., S-Mellado, L. S., Medrano, M., García-Velasco, J. A., & Varela, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111541 · Cited by 27
Telomere length, arsenic exposure and risk of basal cell carcinoma of skin
Srinivas, N., Rachakonda, P. S., Hielscher, T., Calderazzo, S., Rudnai, P., Gurzau, E. S., Koppová, K., Fletcher, T., & Kumar, R. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz059 · Cited by 32
Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia
Fabris, L., Juráček, J., & Călin, G. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186720 · Cited by 27
“Telomeres are nucleoprotein structures at the ends of eukaryotic chromosomes, which maintain genome stability by protecting the ends of chromosomes from fusion and degradation [59].”
BackgroundLuo, Z., Liu, W., Sun, P., Wang, F., & Feng, X. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa441 · Cited by 29
Telomere Biology—Insights into an Intriguing Phenomenon
Venkatesan, S., Khaw, A. K., & Hande, M. P. (2017) · Cells · doi:10.3390/cells6020015 · Cited by 30
Piñeiro‐Hermida, S., Bosso, G., Sánchez-Vazquez, R., Martínez, P., & Blasco, M. A. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01149-6 · Cited by 30
“Thus, telomerase is considered an anti-cancer target [14, 15].”
BackgroundSelf-citationEkiz, G., Yılmaz, S., Yusufoglu, H. S., Ballar, P., & Bedіr, E. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00336 · Cited by 25
Duman, S., Ekiz, G., Yılmaz, S., Yusufoglu, H. S., Ballar, P., & Bedіr, E. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104708 · Cited by 23
Wang, Z., & Wu, X. (2021) · Oncology Reports · doi:10.3892/or.2021.8135 · Cited by 29
Gu, W. L., Lin, Z., Zhao, S., Wang, G., Shen, Z., Liu, W., Cai, Y., Wang, K., Wan, C. C., & Yan, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2905663 · Cited by 27
“Furthermore, this will lead to cell cycle arrest and induction of cellular senescence and apoptosis through p53 and other signaling pathways [7 – 11].”
Implication of asana, pranayama and meditation on telomere stability
Abraham, J., & Rathore, M. (2018) · International Journal of Yoga · doi:10.4103/ijoy.ijoy_51_17 · Cited by 28
“Under physiological conditions, such unstable telomere has been associated with diseases linked with aging and stress exposure, including diabetes mellitus, obesity, heart disease, chronic obstructive pulmonary disease, asthma, cancer, as well as psychiatric illnesses, such as depression, anxiety, posttraumatic stress…”
BackgroundSolana, C., Pereira, D., & Tarazona, R. (2018) · Brain Sciences · doi:10.3390/brainsci8100188 · Cited by 24
“Finally, inheritable gene mutations affecting the telomerase or the telomere protein complex, resulting in decreased telomere lengths (short telomere syndromes, STSs) [50,51].”
BackgroundThe decline of pregnancy rate and abnormal uterine responsiveness of steroid hormones in aging mice
Li, M., Yao, M.-N., Yan, J., Li, Z., Gu, X., Lin, S., Hu, W. M., & Yang, Z. (2017) · Reproductive Biology · doi:10.1016/j.repbio.2017.09.001 · Cited by 19
Telomeres, aging and reproduction
Córdova-Oriz, I., Chico-Sordo, L., & Varela, E. (2022) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000779 · Cited by 23
“These are called telomeric repeat-containing RNA (TERRAs), implicated in telomere protection and transcription, and the control of telomere length [7,10,11].”
BackgroundInfluentialTelomere biology in aging and cancer: early history and perspectives
Hayashi, M. (2017) · Genes & Genetic Systems · doi:10.1266/ggs.17-00010 · Cited by 25
Premature aging and metabolic diseases: the impact of telomere attrition
Jinesh, S., Özüpek, B., & Aditi, P. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1541127 · Cited by 27
“Telomere attrition of stem cells is considered one of the primary molecular mechanisms underlying aging and the development of age-related disorders (Martínez and Blasco, 2017).”
Potential Telomere-Related Pharmacological Targets
Berei, J., Eckburg, A., Miliavski, E., Anderson, A. D., Miller, R. J., Dein, J., Giuffre, A. M., Tang, D., Deb, S., Racherla, K. S., et al. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200109114339 · Cited by 21
Long-lived post-mitotic cell aging: is a telomere clock at play?
Burbano, M. S. J., & Gilson, É. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111256 · Cited by 22
Key Molecular Mechanisms of Aging, Biomarkers, and Potential Interventions
Proshkina, E., Solovev, I. A., Shaposhnikov, M. V., & Moskalev, A. (2020) · Molecular Biology · doi:10.1134/s0026893320060096 · Cited by 21
New Trends in Aging Drug Discovery
Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., López-Rodríguez, M. L., & Ortega‐Gutiérrez, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082006 · Cited by 22
“Another possibility relies on strategies aimed at inducing telomere elongation [209] since T cells from healthy centenarians show longer telomeres and higher telomerase activity in response to stimulation compared to other centenarians.”
BackgroundPremature aging in genetic diseases: what conclusions can be drawn for physiological aging
Milosic, F., Hengstschläger, M., & Osmanagic‐Myers, S. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1327833 · Cited by 25
“…as the primary cause of damage in WS and CS and uniform color in HGPS, no prevalent primary cause of damage in HGPS. classical DNA polymerase to synthetize telomeric repeats at chromosome ends that cannot be entirely compensated by telomerase reverse transcriptase (Martinez and Blasco, 2017).”
BackgroundA single-cell atlas of lung homeostasis reveals dynamic changes during development and aging
Jia, H., Chang, Y., Chen, Y., Chen, X., Zhang, H., Hua, X., Xu, M., Sheng, Y., Zhang, N., Cui, H., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06111-x · Cited by 22
“For instance, some studies, such as the adeno-associated vector mediated telomerase reverse transcriptase protein expression 80 , have not progressed beyond preclinical testing in animal models.”
Zhao, Z., Tan, Q., Zhan, X., Lin, J., Fan, Z., Xiao, K., Li, B., Liao, Y., & Huang, X. (2018) · Theranostics · doi:10.7150/thno.27680 · Cited by 18
“ribonucleoprotein that ensures the accuracy of the coding of genetic information in the chromosomes from each cell division [12, 13].”
BackgroundEmehiser, R. G., Hall, E., Guenther, D. C., Karmakar, S., & Hrdlicka, P. J. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob02111f · Cited by 18
Tyrkalska, S. D., Candel, S., Pedoto, A., García‐Moreno, D., Alcaraz‐Pérez, F., Sánchez‐Ferrer, Á., Cayuela, M. L., & Mulero, V. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac042 · Cited by 20
The role of telomere and telomerase in cancer and novel therapeutic target: narrative review
Baylie, T., Jemal, M., Baye, G., Getinet, M., Amare, G. A., Adugna, A., Abebaw, D., Teffera, Z. H., Tegegne, B. A., Gugsa, E., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1542930 · Cited by 19
“Numerous strategies, including antisense oligonucleotides, G-quadruplex stabilizers, immunotherapy, small-molecule inhibitors, gene therapy, Telomerase-Responsive Drug Release System have been developed in the hunt for telomerase inhibitors (45).”
Ключевые молекулярные механизмы старения, биомаркеры и потенциальные интервенции
Proshkina, E., Соловьёв, И. А., Shaposhnikov, M. V., & Moskalev, A. A. (2020) · Molecular Biology · doi:10.31857/s0026898420060099 · Cited by 21
TRIM28 inhibits alternative lengthening of telomere phenotypes by protecting SETDB1 from degradation
Wang, C., Songyang, Z., & Huang, Y. Y. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00660-y · Cited by 19
Idiopathic Pulmonary Fibrosis and Telomeres
Mulet, A., & Signes‐Costa, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236893 · Cited by 22
Of Cytometry, Stem Cells and Fountain of Youth
Gałkowski, D., Ratajczak, M. Z., Kocki, J., & Darżynkiewicz, Z. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9733-5 · Cited by 19
Short and dysfunctional telomeres protect from allergen‐induced airway inflammation
Piñeiro‐Hermida, S., Martínez, P., & Blasco, M. A. (2021) · Aging Cell · doi:10.1111/acel.13352 · Cited by 18
“Although at the moment different therapeutic approaches for telomerase- based treatment of cancer have been investigated without success, telomeres remain as potential therapeutic targets in oncology (Bejarano et al., 2017; García- Beccaria et al., 2015; Martínez & Blasco, 2017).”
BackgroundSelf-citation
Metadata
- Authors
- Martínez, P., & Blasco, M. A.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre, Madrid E-28029, Spain
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2017-03-02
- Volume
- 216
- Issue
- 4
- Pages
- 875-887
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC5379954
- OpenAlex
- W2592919828
- Cited by
- 257
- References
- 148
- Citations by year
- 2026: 13 · 2025: 20 · 2024: 22 · 2023: 21 · 2022: 33 · 2021: 43 · 2020: 38 · 2019: 21 · 2018: 33 · 2017: 13
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- Spanish Ministry of Economy and Competitiveness
- Fondo Europeo de Desarrollo Regional (SAF2013-45111-R)
- European Research Council (ERC-2008-AdG/232854)
- Fundación Botín
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomeres, telomere shortening, aging, Hoyeraal-Hreidarsson syndrome, dyskeratosis congenita, pulmonary fibrosis, aplastic anemia, liver fibrosis, chromosomal instability, carcinogenesis, shelterin, telomere maintenance genes, cancer, stem cell proliferation, mouse model
- MeSH terms
- Aging, Animals, Cell Transformation, Neoplastic, Fetal Growth Retardation, Humans, Intellectual Disability, Microcephaly, Mutation, Neoplasms, Telomere, Telomerase, Dyskeratosis Congenita, Chromosomal Instability, Molecular Targeted Therapy, Telomere Homeostasis, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.